Literature DB >> 23942579

A trial-based approach to statin guidelines.

Paul M Ridker1, Peter W F Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23942579     DOI： 10.1001/jama.2013.276529

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  High-Quality Statin Trials Support the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines After the HOPE-3 Trial (Heart Outcomes Prevention Evaluation-3): MESA (The Multiethnic Study of Atherosclerosis).

Authors:  Martin Bødtker Mortensen; Matthew Budoff; Dong Li; Khurram Nasir; Michael J Blaha; Veit Sandfort; Carlos Jose Rodriguez; Pamela Ouyang; Erling Falk
Journal:  Circulation       Date:  2017-06-20       Impact factor: 29.690

2.  Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.

Authors:  Martin Bødtker Mortensen; Erling Falk; Dong Li; Khurram Nasir; Michael J Blaha; Veit Sandfort; Carlos Jose Rodriguez; Pamela Ouyang; Matthew Budoff
Journal:  JACC Cardiovasc Imaging       Date:  2017-07-25

3.  Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.

Authors:  Jean S Kutner; Patrick J Blatchford; Donald H Taylor; Christine S Ritchie; Janet H Bull; Diane L Fairclough; Laura C Hanson; Thomas W LeBlanc; Greg P Samsa; Steven Wolf; Noreen M Aziz; David C Currow; Betty Ferrell; Nina Wagner-Johnston; S Yousuf Zafar; James F Cleary; Sandesh Dev; Patricia S Goode; Arif H Kamal; Cordt Kassner; Elizabeth A Kvale; Janelle G McCallum; Adeboye B Ogunseitan; Steven Z Pantilat; Russell K Portenoy; Maryjo Prince-Paul; Jeff A Sloan; Keith M Swetz; Charles F Von Gunten; Amy P Abernethy
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

4.  Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.

Authors:  David J Heller; Pamela G Coxson; Joanne Penko; Mark J Pletcher; Lee Goldman; Michelle C Odden; Dhruv S Kazi; Kirsten Bibbins-Domingo
Journal:  Circulation       Date:  2017-07-07       Impact factor: 29.690

5.  Moneyball, gambling, and the new cholesterol guidelines.

Authors:  Rodney A Hayward
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-03-04

Review 6.  Results of the 4D study: ten years of follow-up?

Authors:  Christoph Wanner; Kai-Renke Schmidt; Vera Krane
Journal:  Clin Exp Nephrol       Date:  2013-10-29       Impact factor: 2.801

7.  Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study.

Authors:  Annick Alpérovitch; Tobias Kurth; Marion Bertrand; Marie-Laure Ancelin; Catherine Helmer; Stéphanie Debette; Christophe Tzourio
Journal:  BMJ       Date:  2015-05-19

8.  Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.

Authors:  Jason L Vassy; Bing Lu; Yuk-Lam Ho; Ashley Galloway; Sridharan Raghavan; Jacqueline Honerlaw; Laura Tarko; John Russo; Saadia Qazi; Ariela R Orkaby; Vidisha Tanukonda; Luc Djousse; J Michael Gaziano; David R Gagnon; Kelly Cho; Peter W F Wilson
Journal:  JAMA Netw Open       Date:  2020-07-01

9.  Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning.

Authors:  Greggory J Schell; Wesley J Marrero; Mariel S Lavieri; Jeremy B Sussman; Rodney A Hayward
Journal:  MDM Policy Pract       Date:  2016-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.